Anemias Video Channel

Explore the latest insights and summaries from experts in Anemias.

Therapeutic Agents

19:28

Agios

Pyruvate Kinase Deficiency: Clinical Manifestations and Treatment Approach

FEATURING Kleber Yotsumoto Fertrin
  • 2,795 views
  • May 15, 2024
  • 5
18:15

Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

Updates in Cellular Therapy for Sickle Cell Disease and Beta-Thalassemia

FEATURING Scott Peslak
  • 119 views
  • March 4, 2024
  • 1
07:27

Catherine Broome

Sutimlimab in Cold Agglutinin Disease: Safety From the Phase 3 Cardinal and Cadenza Studies

  • 239 views
  • April 15, 2024
33:17

Indy Hematology Review

Managing Benign Hematology Disorders

FEATURING Craig Kessler
  • 637 views
  • May 3, 2024
18:18

ACC 2024 Insights

ACC 2024 Insights: Pumping Iron - Treating Iron Deficiency in Heart Failure

FEATURING Nancy Albert
  • 1,796 views
  • May 7, 2024
  • 11
24:53

Steven Fein

Identifying and Treating Iron Deficiency in Pregnancy

  • 534 views
  • May 7, 2024
  • 5
07:59

Keck School of Medicine of USC

CARDINAL Trial 2-Year Follow-Up: Long-Term Sutimlimab for Patients With Cold Agglutinin Disease

FEATURING Ilene Weitz
  • 158 views
  • May 23, 2024
06:49

Kevin Kuo

The Impact of Mitapivat Treatment on Work/School Activity for Adult Patients With Pyruvate Kinase Deficiency

  • 451 views
  • May 24, 2024
22:22

Irina Murakhovskaya

Cold Agglutinin Disease: Pharmacologic Treatment and Clinical Monitoring

  • 222 views
  • June 12, 2024
  • 1
61:22

KDIGO

A Contemporary Approach to Treatment of Anemia for Dialysis Patients: A KDIGO Perspective - The Importance of Nurse-Nephrologist Integrated Care in Anemia Management

FEATURING Lillian Pryor
  • 159 views
  • June 19, 2024
  • 2
09:22

Stefan Eber

Mitapivat in PKD: Results of the ACTIVATE Trial and Updated Treatment Guidelines

  • 621 views
  • June 26, 2024
  • 1
05:59

Stefan Eber

Mitapivat for Thalassemia: Results From the Ph3 ENERGIZE-T Study

  • 159 views
  • July 9, 2024
  • 1
20:56

Kelly Davidson

Sutimlimab in Cold Agglutinin Disease

  • 167 views
  • July 22, 2024
  • 3
10:29

Catherine Broome

2-Year Results From the CARDINAL Study: Sutimlimab for Complement C1s Inhibition in Cold Agglutinin Disease

  • 67 views
  • July 22, 2024
08:05

Ali Taher

Mitapivat in Adults With Alpha- or Beta-Non-Transfusion-Dependent Thalassemia: Results From the Ph3 ENERGIZE Study

  • 40 views
  • July 29, 2024
18:39

Sigbjørn Berentsen

CAD: The Importance of Treatment Continuity

  • 69 views
  • August 5, 2024
10:40

XV Eurasian Hematology-Oncology Congress - EHOC 2024

Shifting Paradigms: Exploring Enarodustat for Anemia in Chronic Kidney Disease in a Meta Analysis of RCTs

FEATURING Ahmet Sarici
  • 16 views
  • August 15, 2024
19:58

XV Eurasian Hematology-Oncology Congress - EHOC 2024

Luspatercept and Blood Transfusion Management in Beta Thalassemia and MDS

FEATURING Anıl Tombak
  • 23 views
  • August 15, 2024
14:49

Hazem Mohammed

Mitapivat in PKD: Meta Analysis of Clinical Trials and Real-World Data

  • 110 views
  • September 3, 2024
  • 4
15:43

Ilham Youssry

Importance of PK Activation in Thalassemias

  • 24 views
  • October 14, 2024
  • 1
22:08

28th Annual Heart Failure 2024: An Update on Therapy

Intravenous Iron for Heart Failure: Where Is the Evidence?

FEATURING Ileana Pina
  • 2,000 views
  • October 22, 2024
  • 24
16:58

Robert Klaassen

Optimal Life-Long Management and Curative Therapies for Transfusion-Dependent Thalassemia

  • 68 views
  • November 7, 2024
13:08

Nita Radhakrishnan

Principles of Iron Management in Thalassemia

  • 138 views
  • November 13, 2024
  • 3
05:58

Akshat Jain

Withdrawal of Voxelotor: Implications for Clinical Practice in Sickle Cell Disease

  • 145 views
  • November 22, 2024
  • 1
23:39

Soteroula Christou

Thalassemias: Managing Iron Overload and Associated Complications

  • 25 views
  • December 4, 2024
  • 1
11:30

2024 ASH Annual Meeting Insights Hub

ASH 2024 Insights: Clinical Importance of Achieving Hb ≥10 g/dL in Transfusion-Dependent ESA-Naïve LR-MDS Pts Treated With Luspatercept - COMMANDS Trial

FEATURING Valeria Santini
  • 17 views
  • December 16, 2024
07:02

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Next-Generation HbS Polymerization Inhibitor GBT021601 for Pts With SCD"

FEATURING Santosh Saraf
  • 52 views
  • January 17, 2024
09:33

Nirmish Shah

Recent Gene Therapy Approvals in SCD: Clinical and Logistical Considerations

  • 141 views
  • February 12, 2024
  • 2
10:22

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

State-of-the-Art in Managing Thalassemias

FEATURING Maria Cappellini
  • 97 views
  • February 13, 2024
12:24

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

The Role of Luspatercept in Transfusion-Dependent Patients With Beta Thalassemia - A Case Discussion

FEATURING Anıl Tombak
  • 49 views
  • February 13, 2024
09:49

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Bu-Cy or Treosulfan-Flu-Thiotepa-Based Myeloablative Conditioning for Children With Thalassemia Major

FEATURING Nihan Bayram
  • 13 views
  • February 13, 2024